These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35057550)

  • 21. Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways.
    Jaidee R; Kukongviriyapan V; Senggunprai L; Prawan A; Jusakul A; Laphanuwat P; Kongpetch S
    Life Sci; 2022 May; 296():120427. PubMed ID: 35218764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy.
    Song J; Xu J; Guo J; Shang Y; Wang J; Wang T
    Acta Histochem; 2021 Sep; 123(6):151769. PubMed ID: 34416437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells.
    Kim HJ; Gong MK; Yoon CY; Kang J; Yun M; Cho NH; Rha SY; Choi YD
    Yonsei Med J; 2020 Jul; 61(7):587-596. PubMed ID: 32608202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells.
    Kim H; Lee SJ; Lee IK; Min SC; Sung HH; Jeong BC; Lee J; Park SH
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer.
    Yang Y; Zhang LJ; Bai XG; Xu HJ; Jin ZL; Ding M
    Biomed Pharmacother; 2018 Oct; 106():1307-1316. PubMed ID: 30119201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nicotine Induces Tumor Growth and Chemoresistance through Activation of the PI3K/Akt/mTOR Pathway in Bladder Cancer.
    Yuge K; Kikuchi E; Hagiwara M; Yasumizu Y; Tanaka N; Kosaka T; Miyajima A; Oya M
    Mol Cancer Ther; 2015 Sep; 14(9):2112-20. PubMed ID: 26184482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guggulsterone induces apoptosis and inhibits lysosomal-dependent migration in human bladder cancer cells.
    Chen Y; Wang HH; Chang HH; Huang YH; Wang JR; Changchien CY; Wu ST
    Phytomedicine; 2021 Jul; 87():153587. PubMed ID: 34044254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cuprous oxide nanoparticles trigger reactive oxygen species-induced apoptosis through activation of erk-dependent autophagy in bladder cancer.
    Xiong Q; Liu A; Ren Q; Xue Y; Yu X; Ying Y; Gao H; Tan H; Zhang Z; Li W; Zeng S; Xu C
    Cell Death Dis; 2020 May; 11(5):366. PubMed ID: 32409654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oleanolic acid suppresses the proliferation of human bladder cancer by Akt/mTOR/S6K and ERK1/2 signaling.
    Mu DW; Guo HQ; Zhou GB; Li JY; Su B
    Int J Clin Exp Pathol; 2015; 8(11):13864-70. PubMed ID: 26823699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathway.
    Shen Z; Xue D; Wang K; Zhang F; Shi J; Jia B; Yang D; Zhang Q; Zhang S; Jiang H; Luo D; Li X; Zhong Q; Zhang J; Peng Z; Han Y; Sima C; He X; Hao L
    BMC Urol; 2022 May; 22(1):79. PubMed ID: 35610639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of metformin enhancing the sensitivity of human pancreatic cancer cells to gem-citabine by regulating the PI3K/Akt/mTOR signaling pathway.
    Zhou HY; Yao XM; Chen XD; Tang JM; Qiao ZG; Wu XY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10283-10289. PubMed ID: 31841183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo and in vitro effects of RAD001 on bladder cancer.
    Vasconcelos-Nóbrega C; Pinto-Leite R; Arantes-Rodrigues R; Ferreira R; Brochado P; Cardoso ML; Palmeira C; Salvador A; Guedes-Teixeira CI; Colaço A; Palomino LF; Lopes C; Santos L; Oliveira PA
    Urol Oncol; 2013 Oct; 31(7):1212-21. PubMed ID: 22169072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
    BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-Caryophyllene induces apoptosis and inhibits cell proliferation by deregulation of STAT-3/mTOR/AKT signaling in human bladder cancer cells: An in vitro study.
    Yu X; Liao B; Zhu P; Cheng S; Du Z; Jiang G
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22863. PubMed ID: 34318533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvianolic acid A reverses cisplatin resistance in lung cancer A549 cells by targeting c-met and attenuating Akt/mTOR pathway.
    Tang XL; Yan L; Zhu L; Jiao DM; Chen J; Chen QY
    J Pharmacol Sci; 2017 Sep; 135(1):1-7. PubMed ID: 28939129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multikinase inhibitor motesanib enhances the antitumor effect of cisplatin in cisplatin‑resistant human bladder cancer cells via apoptosis and the PI3K/Akt pathway.
    Ho JN; Byun SS; Lee SE; Youn JI; Lee S
    Oncol Rep; 2019 Apr; 41(4):2482-2490. PubMed ID: 30816494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of polyphenol extractions from olive pomace and solid fraction of olive mill waste water.
    Tercan S; Seker M
    Nat Prod Res; 2012; 26(19):1837-41. PubMed ID: 22085324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis of bladder cancer by sodium butyrate and cisplatin.
    Maruyama T; Yamamoto S; Qiu J; Ueda Y; Suzuki T; Nojima M; Shima H
    J Infect Chemother; 2012 Jun; 18(3):288-95. PubMed ID: 22041988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.
    Yang Z; Zhao N; Cui J; Wu H; Xiong J; Peng T
    Cell Oncol (Dordr); 2020 Feb; 43(1):123-136. PubMed ID: 31713003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gemcitabine inhibits cisplatin resistance in cisplatin-resistant A549 cells by upregulating trx-interacting protein and inducing cell cycle arrest.
    Cao W; Yang Q; Yuan Z; Li H; Wang W; Xiao X; Wang Z; Liang L; Zhou P; Liu J; Hu X; Zhang B
    Biochem Biophys Res Commun; 2020 Apr; 524(3):549-554. PubMed ID: 32014255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.